1. Volume 73, Pages S53-S68 (April 2008)
Guideline 4: Management of HCV-infected patients before and after kidney transplantation 
Kidney International 
Volume 73, Pages S53-S68 (April 2008)
DOI: /ki
Copyright © 2008 International Society of Nephrology Terms and Conditions

2. Algorithm 2
Pretransplant evaluation for HCV infection. Early viral response patients have a >2 log decrease in viral titer. EIA, enzyme immunoassay; HCV, hepatitis C virus; IFN, interferon; NAT, nucleic acid test.
Kidney International  , S53-S68DOI: ( /ki )
Copyright © 2008 International Society of Nephrology Terms and Conditions

3. Algorithm 3
Management of the wait-listed pretransplant candidate. EIA, enzyme immunoassay; HCV, hepatitis C virus; NAT, nucleicacid test; SVR, sustained virologic response. *For Metavir 1 and 2, liver biopsy is recommended every 5 years; for Metavir 3, liver biopsy is recommended every 3 years.
Kidney International  , S53-S68DOI: ( /ki )
Copyright © 2008 International Society of Nephrology Terms and Conditions

4. Kidney International 2008 73, S53-S68DOI: (10.1038/ki.2008.87)
Copyright © 2008 International Society of Nephrology Terms and Conditions

5. Kidney International 2008 73, S53-S68DOI: (10.1038/ki.2008.87)
Copyright © 2008 International Society of Nephrology Terms and Conditions

6. Kidney International 2008 73, S53-S68DOI: (10.1038/ki.2008.87)
Copyright © 2008 International Society of Nephrology Terms and Conditions

7. Kidney International 2008 73, S53-S68DOI: (10.1038/ki.2008.87)
Copyright © 2008 International Society of Nephrology Terms and Conditions